秘营昌, 罗成伟. 异基因干细胞移植与化疗作为急性髓系白血病缓解后治疗的前瞻性配对研究[J]. 循证医学, 2015, 15(2): 79-82. DOI: 10.3969/j.issn.1671-5144.2015.02.007
    引用本文: 秘营昌, 罗成伟. 异基因干细胞移植与化疗作为急性髓系白血病缓解后治疗的前瞻性配对研究[J]. 循证医学, 2015, 15(2): 79-82. DOI: 10.3969/j.issn.1671-5144.2015.02.007
    MI Ying-chang, LUO Cheng-wei. Allogeneic Transplantation Versus Chemotherapy as Postremission Therapy for Acute Myeloid Leukemia: A Prospective Matched Pairs Analysis[J]. Journal of Evidence-Based Medicine, 2015, 15(2): 79-82. DOI: 10.3969/j.issn.1671-5144.2015.02.007
    Citation: MI Ying-chang, LUO Cheng-wei. Allogeneic Transplantation Versus Chemotherapy as Postremission Therapy for Acute Myeloid Leukemia: A Prospective Matched Pairs Analysis[J]. Journal of Evidence-Based Medicine, 2015, 15(2): 79-82. DOI: 10.3969/j.issn.1671-5144.2015.02.007

    异基因干细胞移植与化疗作为急性髓系白血病缓解后治疗的前瞻性配对研究

    Allogeneic Transplantation Versus Chemotherapy as Postremission Therapy for Acute Myeloid Leukemia: A Prospective Matched Pairs Analysis

    /

    返回文章
    返回